Bayer Germany Reverse-Switches Phytohustil, Expands Iberogast
Executive Summary
Bayer Vital is taking the unusual step to reverse-switch its Phytohustil range of herbal cough medicines in Germany, to strengthen the role of pharmacy in ensuring consumers access the right products for their needs. The company is also launching a new celandine-free addition to its embattled Iberograst brand of herbal gastrointestinal medicines.
You may also be interested in...
Bayer Raises Consumer Health Guidance Following Double-Digit Gain In Q2
Bayer believes its Consumer Health business has the potential to grow at twice the rate of the global market in 2021 following a double-digit rise in sales in the second quarter.
Bayer’s Innovation Engine Shifts Up A Gear To Propel Turnaround
Bayer stepped up its Consumer Health innovation efforts in 2020 in line with its turnaround plan for the business, and now has more than 100 projects in development.
In Bayer North America Executive Moves, Consumer Chief Lockwood-Taylor Adds US Business Top Post
Lockwood-Taylor will start post on 1 August while continuing as North America consumer health chief. Also in North America, Dave Tomasi adds chief commercial officer post and Jeff Jarrett moves to chief marketing officer.